‘Immunocompromised Patients’ Response to COVID Vaccines – The OCTAVE study explained
Clare Jacklin, NRAS CEO in conversation with Professor Stefan Siebert of Glasgow University. The topic of discussion is to gain a better understanding of what the findings from the OCTAVE study tell us for those living with inflammatory arthritis.
Recorded from an NRAS Facebook live session on 29 September 2021.
Видео ‘Immunocompromised Patients’ Response to COVID Vaccines – The OCTAVE study explained канала NRAS_UK
Recorded from an NRAS Facebook live session on 29 September 2021.
Видео ‘Immunocompromised Patients’ Response to COVID Vaccines – The OCTAVE study explained канала NRAS_UK
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
What is the National Early Inflammatory Arthritis Audit? - Dr. James Galloway
Clare Jacklin interviews Professor Peter C Taylor
At what age do people get Rheumatoid Arthritis (RA)?
Do people understand their RA treatment outcomes?
Time2Work Event | Kyla Sanders
A Yearly Update on Medication and Research - 16th November 2021
Why you SHOULD Volunteer for NRAS! 🤝
Time2Work Event | Rheumatoid Arthritis and Work (Full Highlights)
Apni Jung - Early Journey and information from Rheumatology Multi-Disciplinary Team
Getting the most out of your Rheumatology Consultations - Tracy French
Julia's Story - We R.A. Priority
Patient introduction to Workwise Workshop
Beating LONELINESS while living with RA!
The official NRAS trailer drops in 24 hours!
Focusing on Feet - NRAS Foot Health
Professor Peter Taylor's NRAS Members Day 2012 Presentation Part 2
Top tips on celebrating Diwali with Rheumatoid Arthritis
The Importance of Exercise in Inflammatory Arthritis - Professor George Metsios
Exercise with RA: Push-ups from a Chair Exercise
Apni Jung - Example Patient Consultation with GP
RA Awareness Week 2015 - RA simulation glove